Camacho De Arreola v. Colvin

District Court, N.D. California·Decided March 31, 2025·No. 3:24-cv-04997·Unknown

Opinion

ROSELIA A., Case No. 3:24-cv-04997-JSC

Plaintiff, ORDER REVERSING IN PART AND v. REMANDING FOR FURTHER PROCEEDINGS LELAND DUDEK, Acting Commissioner, Re: Dkt. Nos. 8, 12 Defendant.

Plaintiff seeks social security benefits for a combination of physical impairments including degenerative disc disease, osteoarthrosis of bilateral knees, obesity, hypertension, type II diabetes mellitus, mild anemia, mild obstructive sleep apnea, and adrenal insufficiency. (Administrative Record (“AR”) 95-96, 442.) Pursuant to 42 U.S.C. § 405(g), Plaintiff filed this lawsuit for judicial review of the final decision by the Commissioner of Social Security denying her benefits claim. After careful consideration of the parties’ briefing, the Court concludes oral argument is unnecessary, see N.D. Cal. Civ. L.R. 7-1(b), REVERSES the ALJ’s decision in part and REMANDS for further proceedings. Substantial evidence does not support the ALJ’s findings as to Plaintiff’s subjective pain testimony or as to the persuasiveness of Dr. Beltran’s findings regarding Plaintiff’s limitations. A. Procedural History Pursuant to the Social Security Act, on July 14, 2021, Plaintiff filed an application under Titles II for disability insurance benefits alleging a disability onset date of September 4, 2020. (AR 93, 630.) Plaintiff’s application was denied initially and upon reconsideration. (AR 93, 442-474.) 93.) A telephone hearing was held on September 13, 2023 at which Plaintiff, assisted by a Spanish language interpreter, and a vocational expert testified. (AR 415-440.) On October 31, 2023, the ALJ issued an unfavorable decision finding Plaintiff was not disabled within the meaning of the Social Security Act. (AR 93-110.) Plaintiff filed a timely request for review with the Appeals Council, which the Appeals Council denied. (AR 1-4.) Plaintiff thereafter filed the underlying action. In accordance with Civil Local Rule 16-5, the parties filed cross briefs on appeal. (Dkt. Nos. 8, 12.1) B. Issues for Review 1. Did the ALJ err in failing to find Plaintiff’s secondary adrenal insufficiency a severe impairment at step two? 2. Did the ALJ err in evaluating Plaintiff’s subjective symptom testimony? 3. Did the ALJ err in evaluating the medical evidence? A claimant is considered “disabled” under the Act if she meets two requirements. See 42 U.S.C. § 423(d); Tackett v. Apfel, 180 F.3d 1094, 1098 (9th Cir. 1999). First, the claimant must demonstrate “an inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than 12 months.” 42 U.S.C. § 423(d)(1)(A). Second, the impairment or impairments must be severe enough she is unable to do her previous work and cannot, based on her age, education, and work experience, “engage in any other kind of substantial gainful work which exists in the national economy.” Id. § 423(d)(2)(A). To determine whether a claimant is disabled, an ALJ is required to employ a five-step sequential analysis, examining: (1) whether the claimant is engaging in “substantial gainful activity”; (2) whether the claimant has a “severe medically determinable physical or mental impairment” or combination of impairments that has lasted for more than 12 months; (3) whether the impairment “meets or equals” one of the listings in the regulations; (4) whether, given the claimant’s RFC, she can still do her “past relevant work”; and (5) whether the claimant “can make an adjustment to other work.” Molina v. Astrue, 674 F.3d 1104, 1110 (9th Cir. 2012), superseded by regulation on other grounds; see 20 C.F.R. § 404.1520(a). Plaintiff challenges the ALJ’s determination at step two that Plaintiff’s secondary adrenal insufficiency due to high doses of dexamethasone was not a severe impairment. (AR97.) An impairment is considered severe if it “significantly limits the claimant’s physical or mental ability to do basic work activities.” Ford v. Saul, 950 F.3d 1141, 1148 (9th. Cir. 2020) (internal quotation marks and citations omitted). The plaintiff has the burden to demonstrate the existence of a medically determinable impairment through medical evidence. Bowen v. Yuckert, 482 U.S. 137, 146 (1987); see also 20 C.F.R. § 404.1508 (providing claimant must establish existence of medically determinable impairment from “medically acceptable clinical and laboratory diagnostic techniques”). The Ninth Circuit has recognized, however, that the step two inquiry is a “de minimis screening device used to dispose of groundless claims.” Edlund v. Massanari, 253 F.3d 1152, 1158 (9th. Cir. 2001) (internal quotation marks and citation omitted). Indeed, the ALJ can find an impairment or combination of impairments is non-severe “only if the evidence establishes a slight abnormality that has no more than a minimal effect on an individual’s ability to work.” Smolen v. Chater, 80 F.3d 1273, 1290 (9th Cir. 1996) (internal quotation marks and citations omitted); see also 20 C.F.R. § 416.921(a) (an impairment is “severe” if it significantly limits the claimant's physical or mental ability to do basic work activities); 20 C.F.R. § 416.909 (impairment must have lasted or must be expected to last for a continuous period of at least 12 months). On review, this Court’s duty is to determine “whether the ALJ had substantial evidence to find that the medical evidence clearly established that” Plaintiff did not have a severe mental impairment. Webb v. Barnhart, 433 F.3d 683, 687 (9th Cir. 2005). Here, the ALJ noted Plaintiff alleged additional medical impairments of “hypertension, concluded these were not severe because “they have not had more than a minimal effect on her ability to carry out basic work activities for a continuous period of 12 months or more.” (AR 96.) As to the secondary adrenal insufficiency, the ALJ found it was not severe because once diagnosed, it “improved significantly with a hydrocortisone replacement,” and she completed her treatment in July 2023. (AR 97.) Plaintiff contends this was in error because the ALJ failed to consider that her use of the supplement containing dexamethasone was “a major contributing factor to her blood pressure” symptoms of which started in at least March 2021. (Dkt. No. 8 at 10.) Plaintiff insists the adrenal insufficiency was causing other symptoms of high blood pressure, headaches, shortness of breath, nausea, and vomiting. Plaintiff, however, has not offered medical evidence supporting her theory that the adrenal insufficiency caused the other symptoms and resulted in workplace limitations for a period of 12 consecutive months. The ALJ relied on evidence that once the adrenal insufficiency was identified and she stopped taking the supplement with dexamethasone and started a course of hydro

Free access — add to your briefcase to read the full text and ask questions with AI

Camacho De Arreola v. Colvin, (N.D. Cal. 2025).

Camacho De Arreola v. Colvin (Camacho De Arreola v. Colvin) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bowen v. Yuckert
482 U.S. 137 (Supreme Court, 1987)
Molina v. Astrue
674 F.3d 1104 (Ninth Circuit, 2012)
Orn v. Astrue
495 F.3d 625 (Ninth Circuit, 2007)
Jasim Ghanim v. Carolyn W. Colvin
763 F.3d 1154 (Ninth Circuit, 2014)
Michelle Ford v. Andrew Saul
950 F.3d 1141 (Ninth Circuit, 2020)
Leslie Woods v. Kilolo Kijakazi
32 F.4th 785 (Ninth Circuit, 2022)
Jordan v. Fox, Rothschild, O'Brien & Frankel
20 F.3d 1250 (Third Circuit, 1994)
Tackett v. Apfel
180 F.3d 1094 (Ninth Circuit, 1999)